Emergency use authorization of the Mpox vaccine by NAFDAC: A crucial step in Nigeria’s public health response
The 2022 Monkeypox (Mpox) outbreak, initially detected in the United Kingdom, posed a significant global health challenge. The World Health Organization’s declaration of a Public Health Emergency of International Concern underscored the urgency of the situation. In Nigeria, the National Agency for Food and Drug Administration and Control (NAFDAC) took proactive measures to ensure the […]
Unlocking the healthcare value chain: 2nd regional workshop on manufacturing Active Pharmaceutical Ingredients and excipients in Nigeria
Introduction Active Pharmaceutical Ingredients (APIs) are the essential components of pharmaceutical products responsible for the intended therapeutic effect.They form the backbone of pharmaceutical formulation and their quality directly impacts the safety and efficacy of the medicines which directly impacts public health. The National Agency for Food and Drug Administration and control (NAFDAC) has recognised the […]
Regional Workshop on ICH Q1 – Stability Guideline (22nd – 24th July, 2024)
Was this helpful? Yes No Submit Cancel Thanks for your feedback!
Secondary Validation of a Liquid Scintillation Counter-method for Residues of Tetracyclines, Beta-lactams, and Sulfonamides in Seafood/Aquaculture Products
Was this helpful? Yes No Submit Cancel Thanks for your feedback!
The one health Triad
Was this helpful? Yes No Submit Cancel Thanks for your feedback!
Anti-microbial Resistance (AMR)
Was this helpful? Yes No Submit Cancel Thanks for your feedback!
NAFDAC Traceability: Find out all you need to know here
Was this helpful? Yes No Submit Cancel Thanks for your feedback!
